№ files_lp_3_process_9_35200
File format: docx
Character count: 1772
File size: 163 KB
Continuing education event announcement outlining a pharmacy-focused educational lecture on continuous renal replacement therapies, dialysis modalities, and drug dosing considerations in patient care, including objectives, logistics, and participation details.
Year:
2024
Date:
August 19, 2024
Location:
Adventist Health Glendale Hospital, 1509 Wilson Terrace, Glendale, CA 91206
Venue:
Wu Auditorium, East Tower, Ground Floor
Organizing Body:
SGVSHP
Speaker:
Jignesh H. Patel, Pharm.D., B.Sc.
Affiliation:
Western University of Health Sciences, College of Pharmacy
Department:
Pharmacy Practice and Administration
Target Audience:
Pharmacists, Technicians
Activity Type:
Knowledge-based Continuing Education
Continuing Education Credit:
Available
CE Fee:
No charge for CSHP members
Time:
6:30 PM – 8:00 PM PST
Dinner:
5:30 PM – 6:30 PM
Contact Persons:
Duc Bach; Lisa Gunther
RSVP Deadline:
August 16, 2024
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2024
Note:
Region / City
Subject:
Emotional reactivity, aging
Document Type:
Peer review letter
Organization / Institution:
Collabra: Psychology
Author:
Kate Mills
Target Audience:
Researchers in psychology, aging, and emotional reactivity
Year:
2022-2023
Region / City:
Florida
Topic:
Education, Special Education, Accessibility
Document Type:
Official guideline
Organization:
Florida Department of Education (FLDOE)
Author:
Not specified
Target Audience:
Case managers, educators, IEP team members
Period of validity:
Ongoing, annual requests
Approval Date:
Not specified
Date of changes:
Not specified
Year:
2024-2025
Institution:
Howard University
Location:
Washington DC, USA
Authors:
Jasmine C Michel, Diana E Kutai
Corresponding Faculty:
Mary A Ayuk
Research Subject:
Mycobacteriophage Ablatia
Host Organism:
Mycobacterium smegmatis mc2 155
Methodology:
Isolation, purification, DNA extraction, genomic sequencing
Sequencing Platform:
MiSeq, Illumina
Genome Details:
155,479 bps, 231 genes, 32 tRNAs, 1 tmRNA, GC content 64.7%, Myoviridae morphotype
Annotation Tools:
PhagesDB, NCBI BLAST, GeneMark, Glimmer, Starterator, HHpred, DeepTMHMM
Keywords:
Mycobacteriophage, Soil, Mycobacterium smegmatis, Myoviridae
Year:
2025
Region / City:
Southern Africa
Topic:
Ethical Artificial Intelligence in Education
Document Type:
Book Chapter
Institution:
University of Ghana
Author:
Joseph Daniels
Target Audience:
Scholars, educators, policymakers
Approval Date:
2025
Amendment Date:
N/A
DOI:
10.71010/AJSER-2025-e252
Source Article:
American Journal of Science Education Research, 4(6): 1-10
Ethical Issues:
None
Abstract:
The manuscript is comprehensive and well-formulated.
Language Quality:
Suitable for scholarly communication.
Comments:
The manuscript bridges AI ethics with real-world educational applications, emphasizing transparency, fairness, and accountability.
Year:
2026
Region / City:
Not specified
Topic:
Adjectives in a mystery story
Document Type:
Educational content
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Students or readers interested in language
Period of validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2026
Region / City:
Galesburg, Illinois, USA
Topic:
Genetic testing and disease risk
Document Type:
News article / Broadcast segment
Organization:
OSF HealthCare
Author:
Not specified
Target Audience:
General public
Test Type:
Polygenic testing
Diseases Covered:
Cancer, diabetes, stroke, Alzheimer’s disease
Method:
Cheek swab
Cost:
$275
Insurance Coverage:
Not covered
Pilot Program Status:
Early stage
Year:
2025
Region / City:
Aotearoa
Topic:
Ondansetron usage, dosing guidelines, drug interactions
Document Type:
Medical Best Practice Guide
Organization / Institution:
HealthPathways, Health New Zealand, Te Whatu Ora
Author:
Riani Albertyn, Brendan Duck
Target Audience:
Healthcare professionals
Period of Validity:
2025
Approval Date:
March 2025
Date of Changes:
January 2024
Year:
2024
Region / City:
South-East Queensland
Topic:
Water treatment, chemical dosing units
Document Type:
Technical Specification
Organization:
Urban Utilities
Author:
Santhosh Jambagi
Target Audience:
Designers, constructors, and stakeholders involved in chemical dosing systems for water infrastructure
Period of Validity:
From 31/10/2024
Approval Date:
31/10/2024
Date of Revision:
31/10/2024
Year:
2013
Region / city:
United States
Topic:
Clinical guidelines for vancomycin dosing and management
Document type:
Clinical Protocol
Organization / Institution:
UConn Health – John Dempsey Hospital
Author:
Director of Pharmacy, Dept. of Infectious Diseases
Target audience:
Licensed Prescribers, Pharmacists, Nurses
Period of validity:
Ongoing
Approval date:
10/30/13
Last revision date:
10/2020
Year:
2019
Region / city:
UConn Health – John Dempsey Hospital
Theme:
Clinical Practice
Document Type:
Protocol
Organization / institution:
UConn Health, Department of Pharmacy, Department of Infectious Diseases
Author:
John Dempsey Hospital Pharmacy Department
Target audience:
Licensed Prescribers, Pharmacists, Nurses
Effective Period:
Not specified
Approval Date:
1/9/19
Date of Last Revision:
Not specified
Date Retired:
Not specified
Year:
2019
Organization:
The Royal Australian College of General Practitioners (RACGP)
Document type:
Policy template
Purpose:
Safe limitations for prescribing opioid medication
Scope:
Non-malignant pain
Current as of:
[insert date of last revision]
Version no:
[insert version number]
Review date:
[insert date]
Target audience:
General practitioners
Source:
RACGP Clinical Governance Framework
Year:
2026
Region / City:
Ohio
Topic:
Pediatric Drug Dosing, Infantile Spasms
Document Type:
Medical Response
Organization:
The Ohio State University College of Pharmacy
Author:
Hailey Baird
Target Audience:
Medical Professionals, Pediatric Neurologists
Period of Effectiveness:
2026
Approval Date:
2026
Date of Last Update:
2026
Year:
2026
Institution:
Royal Infirmary of Edinburgh
Department:
Renal Directorate
Document Type:
Clinical guideline
Intended Audience:
Healthcare professionals in nephrology and dialysis units
Indication:
Prevention of clotting in extracorporeal haemodialysis circuits
Dosage Information:
Weight-based Dalteparin administration at start of dialysis
Monitoring:
Anti-Xa levels at 1 and 4 hours post-administration under specific conditions
Contraindications:
Systemic anticoagulation, invasive procedures within 24 hours, hypersensitivity to heparin or LMWHs, haemophilia, severe thrombocytopenia, recent cerebral haemorrhage, severe liver disease, acute peptic ulceration
Side Effects:
Skin rashes, minor bruising, systemic allergic reactions, excessive bleeding, thrombocytopenia, skin necrosis, hyperkalaemia
Reversal:
Protamine sulphate if severe bleeding occurs during or within 2 hours post-dialysis
Year:
Not specified
Region / City:
Not specified
Topic:
Mistletoe therapy dosing
Document type:
Medical Guide
Organization / Institution:
Not specified
Author:
Not specified
Target audience:
Patients receiving mistletoe therapy
Duration:
Long-term therapy
Approval date:
Not specified
Modification date:
Not specified